2/5
09:27 am
ardx
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026 [Yahoo! Finance]
Medium
Report
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026 [Yahoo! Finance]
2/5
08:00 am
ardx
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
Medium
Report
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
2/3
09:12 am
ardx
Ardelyx Receives New Patent for Tenapanor [Yahoo! Finance]
Low
Report
Ardelyx Receives New Patent for Tenapanor [Yahoo! Finance]
2/3
08:29 am
ardx
Ardelyx Receives New Patent for Tenapanor
Low
Report
Ardelyx Receives New Patent for Tenapanor
2/2
09:44 am
ardx
Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results [Yahoo! Finance]
Low
Report
Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results [Yahoo! Finance]
1/29
10:59 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at TD Cowen.
Low
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at TD Cowen.
1/29
08:03 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $17.00 price target on the stock.
Low
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $17.00 price target on the stock.
1/28
07:02 pm
ardx
Is Ardelyx (ARDX) Pricing Reflect Its Strong Multi Year Share Price Performance [Yahoo! Finance]
Low
Report
Is Ardelyx (ARDX) Pricing Reflect Its Strong Multi Year Share Price Performance [Yahoo! Finance]
1/28
12:37 pm
ardx
How Ardelyx's Phase 3 ACCEL Trial for IBSRELA in CIC Will Impact Ardelyx (ARDX) Investors [Yahoo! Finance]
Low
Report
How Ardelyx's Phase 3 ACCEL Trial for IBSRELA in CIC Will Impact Ardelyx (ARDX) Investors [Yahoo! Finance]
1/28
08:29 am
ardx
First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
Low
Report
First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
1/27
07:19 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
1/26
10:16 am
ardx
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
Low
Report
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
1/23
05:06 am
ardx
Ardelyx (NASDAQ:ARDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Ardelyx (NASDAQ:ARDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/21
01:05 pm
ardx
Ardelyx: Assessment Of Acquisition Rumors [Seeking Alpha]
Low
Report
Ardelyx: Assessment Of Acquisition Rumors [Seeking Alpha]
1/21
09:05 am
ardx
Ardelyx (NASDAQ:ARDX) had its price target raised by analysts at Wedbush from $16.00 to $19.00. They now have an "outperform" rating on the stock.
Low
Report
Ardelyx (NASDAQ:ARDX) had its price target raised by analysts at Wedbush from $16.00 to $19.00. They now have an "outperform" rating on the stock.
1/20
10:32 am
ardx
Ardelyx gains on report Zydus Lifesciences in talks to purchase [Seeking Alpha]
Low
Report
Ardelyx gains on report Zydus Lifesciences in talks to purchase [Seeking Alpha]
1/20
06:15 am
ardx
Ardelyx: IBSRELA Momentum Drives Opportunity [Seeking Alpha]
Low
Report
Ardelyx: IBSRELA Momentum Drives Opportunity [Seeking Alpha]
1/9
07:03 pm
ardx
Assessing Ardelyx (ARDX) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
Medium
Report
Assessing Ardelyx (ARDX) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
1/9
07:03 pm
ardx
Why The Ardelyx ARDX Story Is Shifting On New Ibsrela Targets And Valuation Assumptions [Yahoo! Finance]
Medium
Report
Why The Ardelyx ARDX Story Is Shifting On New Ibsrela Targets And Valuation Assumptions [Yahoo! Finance]
1/9
08:43 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
1/9
07:18 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at BTIG Research.
Medium
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at BTIG Research.
1/8
05:04 pm
ardx
Ardelyx (NASDAQ:ARDX) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating.
Medium
Report
Ardelyx (NASDAQ:ARDX) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating.
1/8
02:00 pm
ardx
Ardelyx (NASDAQ:ARDX) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Ardelyx (NASDAQ:ARDX) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
1/8
08:30 am
ardx
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook
High
Report
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook
1/5
09:52 am
ardx
Ardelyx (ARDX) Moves 5.5% Higher: Will This Strength Last? [Yahoo! Finance]
Low
Report
Ardelyx (ARDX) Moves 5.5% Higher: Will This Strength Last? [Yahoo! Finance]